Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)
Apply
PTX-022
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step